Bellevue Group Ag Immunocore Holdings PLC Transaction History
Bellevue Group Ag
- $4.31 Billion
- Q1 2025
A detailed history of Bellevue Group Ag transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Bellevue Group Ag holds 1,221,794 shares of IMCR stock, worth $38 Million. This represents 0.84% of its overall portfolio holdings.
Number of Shares
1,221,794
Previous 1,205,464
1.35%
Holding current value
$38 Million
Previous $35.6 Million
1.94%
% of portfolio
0.84%
Previous 0.71%
Shares
6 transactions
Others Institutions Holding IMCR
# of Institutions
128Shares Held
44.6MCall Options Held
219KPut Options Held
125K-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.05MShares$219 Million0.14% of portfolio
-
Wellington Management Group LLP Boston, MA6.13MShares$191 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$152 Million2.37% of portfolio
-
Primecap Management CO Pasadena, CA2.68MShares$83.4 Million0.07% of portfolio
-
Baker Bros. Advisors LP New York, NY2.32MShares$72.3 Million0.82% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.37B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...